Market & RegulationInvestment · $33M
Tiny Health Raises $33M for Gut Microbiome AI
Crunchbase Newshigh confidence
Why it matters
- →AI is being applied to large-scale microbiome datasets to move from descriptive wellness reports to predictive health modeling.
- →The funding validates the commercial viability of B2B microbiome testing integrated into clinical workflows at major institutions.
- →Proprietary data accumulation becomes a moat as companies race to decode gut health patterns for early disease detection.
Austin-based Tiny Health announced a $33 million Series B funding round led by B Capital, bringing its total capital raised to $46 million. The company plans to use the funds to expand its 'Powered by Tiny' B2B platform and develop 'TinyAI,' an AI-driven tool intended to analyze its growing database of nearly 200,000 microbiome samples for predictive health insights. Tiny Health utilizes shotgun metagenomic sequencing to provide detailed microbial profiles to consumers and over 6,000 healthcare practitioners, including partners like Mayo Clinic. The startup aims to shift the focus from reactive diagnosis to preventive intervention by identifying disease risks before symptoms appear.
Read original
